HiWebsite

Website Overview: fasenrahcp.comopen_in_new

General information

Last Updated: 2024-04-09 (yyyy-mm-dd).

Title: FASENRA benralizumab for Severe Eosinophilic Asthma For HCPs

Description: FASENRA is indicated for the add on maintenance treatment of patients with severe asthma aged 12 years and older and with an eosinophilic phenotype

Fasenrahcp.com Screenshot 2024-06-12 23:11:52

Language: English

Contact information

Telephone

Services and technology that the website used

Vendor

Related Websites